Taizhou, China

Jianqiang Zhao

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Gilead Pharmasset LLC. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianqiang Zhao. Retrieved from https://idiyas.com/inventor/jianqiang-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Taizhou, CN (2017)
  • Zhejiang, CN (2017)

Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Jianqiang Zhao

Introduction

Jianqiang Zhao is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to combat viral infections.

Latest Patents

Jianqiang Zhao holds 2 patents that focus on the preparation of fluorolactone derivatives. His latest patents include a novel process for the preparation of a fluorolactone derivative, which is crucial for synthesizing prodrug compounds. These compounds are important as they have the potential to be potent inhibitors of the Hepatitis C Virus (HCV) NS5B polymerase.

Career Highlights

Zhao is currently employed at Gilead Pharmasset LLC, where he continues to innovate and contribute to the pharmaceutical industry. His work is instrumental in advancing treatments for viral infections, showcasing his commitment to improving public health.

Collaborations

Some of his notable coworkers include Rongmin Chen and Yuanqiang Li, who collaborate with him on various projects within the company.

Conclusion

Jianqiang Zhao's work exemplifies the impact of innovative thinking in the pharmaceutical field. His patents and ongoing research contribute significantly to the fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…